19-2434087-G-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 0P and 2B. BP4_Moderate
The NM_032737.4(LMNB2):c.1221C>A(p.Ser407Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000691 in 1,590,952 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_032737.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
LMNB2 | ENST00000325327.4 | c.1221C>A | p.Ser407Arg | missense_variant | Exon 8 of 12 | 1 | NM_032737.4 | ENSP00000327054.3 | ||
LMNB2 | ENST00000490554.5 | n.412C>A | non_coding_transcript_exon_variant | Exon 3 of 4 | 2 | |||||
LMNB2 | ENST00000532465.1 | n.-188C>A | upstream_gene_variant | 3 | ||||||
LMNB2 | ENST00000527409.1 | n.*208C>A | downstream_gene_variant | 5 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152248Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000720 AC: 15AN: 208230Hom.: 0 AF XY: 0.0000350 AC XY: 4AN XY: 114306
GnomAD4 exome AF: 0.00000695 AC: 10AN: 1438586Hom.: 0 Cov.: 36 AF XY: 0.00000280 AC XY: 2AN XY: 714104
GnomAD4 genome AF: 0.00000656 AC: 1AN: 152366Hom.: 0 Cov.: 33 AF XY: 0.0000134 AC XY: 1AN XY: 74516
ClinVar
Submissions by phenotype
Lipodystrophy, partial, acquired, susceptibility to;C4225289:Progressive myoclonic epilepsy type 9 Uncertain:1
In summary, this variant is a rare missense change with uncertain impact on protein function. There is no indication that it causes disease, but the available evidence is currently insufficient to prove that conclusively. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be disruptive, but these predictions have not been confirmed by published functional studies. This variant is present in population databases (rs766553520, ExAC 0.1%) but has not been reported in the literature in individuals with a LMNB2-related disease. This sequence change replaces serine with arginine at codon 407 of the LMNB2 protein (p.Ser407Arg). The serine residue is highly conserved and there is a moderate physicochemical difference between serine and arginine. -
not specified Uncertain:1
The c.1161C>A (p.S387R) alteration is located in exon 8 (coding exon 8) of the LMNB2 gene. This alteration results from a C to A substitution at nucleotide position 1161, causing the serine (S) at amino acid position 387 to be replaced by an arginine (R). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at